- Tytuł:
- LBA1 Final analysis of the placebo-controlled randomised phase III IMpassion031 trial evaluating neoadjuvant atezolizumab (atezo) plus chemotherapy (CT) followed by open-label adjuvant atezo in patients (pts) with early-stage triple-negative breast cancer (eTNBC)
- Autorzy:
- Źródło:
- In ESMO Open May 2023 8(1) Supplement 4
Czasopismo naukowe